Fundraising Fox

Rejoni

Bedford, US · Founded 2020 · Delaware corporation · 21 employees on LinkedIn · 7 known investors

Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.

BiotechFemTechHealthtechMedical Devices

Founders & leadership

Rejoni was founded in 2020 by AMARPREET SAWHNEY and Amar Sawhney.

ASAMARPREET SAWHNEY
AMARPREET SAWHNEYinCo-founder · CEOAdvisor at Cybernetix Ventures
AS
Amar SawhneyFounder
NS
NICK SVENCERNamed on SEC filing
FK
FARHAD KHOSRAVINamed on SEC filing

Board

TB
TARA BUTLERBoard director

Investors · 7

Ascension VenturesSaint Louis · $10M – $20M
ClavystBioSingapore
Delos CapitalCambridge
FemHealth VenturesShort Hills
Iyengar Capital PartnersClayton
Amed VenturesreportedLewes
Catalyst Health VenturesreportedBoston · $1M – $3M

Funding

SEC filings, press & company announcements

$66.3M disclosed across 3 of 4 rounds · 2020–2026

▶$26.3MraisedOct 2023 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Guneesh BatraDirector
  • Amarpreet SawhneyExecutive Officer, Director
  • Nicholas SvencerExecutive Officer, Director
  • Farhad KhosraviDirector
Offering amount
$26.3M
Amount sold
$26.3M
Minimum investment
$10K
First sale
Dec 2022
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedSep 2020 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • AMARPREET SAWHNEYExecutive Officer, Director, Promoter
  • NICK SVENCERExecutive Officer, Director, Promoter
  • TARA BUTLERExecutive Officer, Director, Promoter
  • FARHAD KHOSRAVIExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$15M
Minimum investment
$20K
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Rejoni Raises $25M to Prepare Uterine Healing Hydrogel for FDA Approval and Launch | Femtech Insiderfemtechinsider.com · Jul 2026Rejoni, Inc. Secures $25 Million in Financing to Accelerate the Juveena® Hydrogel System Toward FDA Approval and Launchfinance.yahoo.com · Jun 2026Rejoni Raises $25 Million to Advance Juveena Hydrogel System Toward FDA Approval | citybizcitybiz.co · Jun 2026Rejoni Raises $25M in Fundingfinsmes.com · Jun 2026Rejoni Closes $25M in Series B Funding Round — FemHealth Venturesfemhealthventures.com · Dec 2022Rejoni Closes $25M Series B Financingfinsmes.com · Dec 2022

Frequently asked questions

What does Rejoni do?
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
Who founded Rejoni?
Rejoni was founded by AMARPREET SAWHNEY, Amar Sawhney in 2020.
Who are Rejoni's investors?
Rejoni's investors include Ascension Ventures, ClavystBio, Delos Capital, FemHealth Ventures, Iyengar Capital Partners, Amed Ventures, Catalyst Health Ventures.
How much funding has Rejoni raised?
Rejoni has disclosed $66.3M raised across 3 of its 4 known rounds.
Where is Rejoni headquartered?
Rejoni is headquartered in Bedford, US.